Skip to main content

Peer Review reports

From: Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

Original Submission
21 Nov 2016 Submitted Original manuscript
4 Apr 2017 Reviewed Reviewer Report - Pablo Maroto
5 Jul 2017 Reviewed Reviewer Report - Frede Donskov
8 Oct 2017 Author responded Author comments - Radek Lakomy
Resubmission - Version 2
8 Oct 2017 Submitted Manuscript version 2
13 Nov 2017 Reviewed Reviewer Report - Frede Donskov
2 Dec 2017 Author responded Author comments - Radek Lakomy
Resubmission - Version 3
2 Dec 2017 Submitted Manuscript version 3
Publishing
8 Dec 2017 Editorially accepted
21 Dec 2017 Article published 10.1186/s12885-017-3901-5

You can find further information about peer review here.

Back to article page